StemRIM (TSE:4599) Additional Paid-In Capital : 円9,214 Mil(As of Apr. 2024)

View and export this data going back to 2019. Start your Free Trial

What is StemRIM Additional Paid-In Capital?

StemRIM's quarterly additional paid-in capital increased from Oct. 2023 (円9,048 Mil) to Jan. 2024 (円9,204 Mil) and increased from Jan. 2024 (円9,204 Mil) to Apr. 2024 (円9,214 Mil).

StemRIM's annual additional paid-in capital increased from Jul. 2021 (円10,500 Mil) to Jul. 2022 (円10,620 Mil) but then declined from Jul. 2022 (円10,620 Mil) to Jul. 2023 (円9,012 Mil).

StemRIM Additional Paid-In Capital Historical Data

The historical data trend for StemRIM's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemRIM Additional Paid-In Capital Chart

StemRIM Annual Data

Trend

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Additional Paid-In Capital

Get a 7-Day Free Trial

2,802.57

10,371.25

10,500.41

10,620.17

9,011.68

StemRIM Quarterly Data
	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
Additional Paid-In Capital	Get a 7-Day Free Trial															8,758.36	9,011.68	9,047.59	9,203.55	9,214.00

StemRIM Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

StemRIM Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of StemRIM's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

StemRIM (TSE:4599) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemRIM Inc (TSE:4599) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085

Website

https://www.stemrim.com

StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.

StemRIM (TSE:4599) Headlines

No Headlines